Literature DB >> 12908520

Characterization of human papillomavirus infection, P53 and Ki-67 expression in cervix cancer of Mozambican women.

Carla Carrilho1, Patricia Gouveia, Martha Cantel, Matos Alberto, Landim Buane, Leonor David.   

Abstract

In this study, we aimed at evaluating the distribution of HPV types and the expression of P53 and Ki-67 in cervix carcinomas of Mozambican women. Fourty-seven invasive carcinomas, 10 CIN III, and 10 normal cervix were studied. P53 and Ki-67 expression was examined immunohistochemically. HPV infection and HPV types were detected by PCR (GP5+/bio-GP6+) and enzyme-immunoassay, respectively. Expression of P53 and Ki-67 and detection of HPV were as follows: normal cervix--0%, 10%, and 0%, respectively; CIN III--10%, 0%, and 100%, respectively; invasive carcinomas--50%, 55.5%, and 70%, respectively. HPV 16 was identified in 54% of invasive carcinomas, HPV 31, 33, 35, and 45 in 23%, "unidentified" HPV in 19%, and HPV 18 in 4% of invasive carcinomas. No significant associations were observed between P53 expression, Ki-67 expression, and HPV infection. In conclusion, we observed a high frequency of HPV infection in CIN III lesions and invasive carcinomas from Mozambican women, with HPV 16 representing the most frequent viral type. HPV status was not related to P53 and Ki-67 expression. Both P53 and Ki-67 are associated with invasive cervix carcinomas, mainly of the squamous keratinizing histotype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12908520     DOI: 10.1078/0344-0338-00422

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  8 in total

1.  Distribution of HPV infection and tumour markers in cervical intraepithelial neoplasia from cone biopsies of Mozambican women.

Authors:  C Carrilho; L Cirnes; M Alberto; L Buane; N Mendes; L David
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

Review 2.  Human papillomavirus (HPV) infection: a Mozambique overview.

Authors:  Damiano Pizzol; Giovanni Putoto; Kajal D Chhaganlal
Journal:  Virusdisease       Date:  2016-05-03

3.  Human papillomaviruses in intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva: a study from Mozambique.

Authors:  Carla Carrilho; Patrícia Gouveia; Hideki Yokohama; José M Lopes; Nuno Lunet; Josefo Ferro; Mamudo Ismail; Jan Walboomers; Manuel Sobrinho-Simões; Leonor David
Journal:  Eur J Cancer Prev       Date:  2013-11       Impact factor: 2.497

4.  Implementation of cervical cancer screening using visual inspection with acetic acid in rural Mozambique: successes and challenges using HIV care and treatment programme investments in Zambézia Province.

Authors:  Troy D Moon; Carla Silva-Matos; Aventina Cordoso; Alberto J Baptista; Mohsin Sidat; Sten H Vermund
Journal:  J Int AIDS Soc       Date:  2012-06-18       Impact factor: 5.396

5.  Human papillomavirus prevalence and genotype distribution among young women and men in Maputo city, Mozambique.

Authors:  Viegas Edna Omar; Augusto Orvalho; Ismael Nália; Malin Kaliff; Gabriella Lillsunde-Larsson; Torbjörn Ramqvist; Charlotta Nilsson; Kerstin Falk; Osman Nafissa; Jani Ilesh Vindorai; Sören Andersson
Journal:  BMJ Open       Date:  2017-07-17       Impact factor: 2.692

6.  Awareness of cervical cancer and willingness to be vaccinated against human papillomavirus in Mozambican adolescent girls.

Authors:  Azucena Bardají; Carolina Mindu; Orvalho J Augusto; Aina Casellas; Olga Cambaco; Egas Simbine; Graça Matsinhe; Eusébio Macete; Clara Menéndez; Esperança Sevene; Khátia Munguambe
Journal:  Papillomavirus Res       Date:  2018-04-14

Review 7.  The Association and Significance of p53 in Gynecologic Cancers: The Potential of Targeted Therapy.

Authors:  Mitsuhiro Nakamura; Takeshi Obata; Takiko Daikoku; Hiroshi Fujiwara
Journal:  Int J Mol Sci       Date:  2019-11-04       Impact factor: 5.923

8.  Human Papillomavirus type distribution in invasive cervical cancer in Uganda.

Authors:  Michael Odida; Silvia de Sanjosé; Wim Quint; Xavier F Bosch; Joellen Klaustermeier; Elisabete Weiderpass
Journal:  BMC Infect Dis       Date:  2008-06-24       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.